The Arab Drug Company

EGX-ADCI
Egyptian Stock Exchange
Pharmaceutical Preparations
Global Rank
#31761
Country Rank
#115
Market Cap
42.83 M
Price
3.53
Change (%)
2.61%
Volume
19,748

The Arab Drug Company's latest marketcap:

42.83 M

As of 09/26/2025, The Arab Drug Company's market capitalization has reached $42.83 M. According to our data, The Arab Drug Company is the 31761th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 42.83 M
Revenue (ttm) 21.34 M
Net Income (ttm) 3.3 M
Shares Out 12 M
EPS (ttm) 0.28
Forward PE 0.00
Ex-Dividend Date 10/28/2024
Earnings Date 09/01/2025
Market Cap Chart
Data Updated: 09/26/2025

The Arab Drug Company's yearly market capitalization.

The Arab Drug Company has seen its market value grow from 71.22 M EGP to 2.06 B EGP since 2014, representing a total increase of 2,791.66% and an annual compound growth rate (CAGR) of 36.79%.
Date Market Cap Market Cap(USD) Change (%) Global Rank
09/26/2025 2.06 B $42.83 M 147.34% 31761
12/31/2024 823.56 M $15.79 M 97.13% 35605
12/31/2023 417.78 M $13.29 M 20.05% 35830
12/29/2022 348 M $13.89 M 10.35% 34496
12/30/2021 315.36 M $19.94 M -31.36% 32767
12/31/2020 459.42 M $28.99 M 81.45% 27712
12/31/2019 253.2 M $15.67 M 60.88% 27346
12/31/2018 157.38 M $8.72 M -13.57% 28286
12/31/2017 182.1 M $10.13 M 219.47% 27595
12/29/2016 57 M $3.05 M 54.98% 27655

Company Profile

About Arab Drug Company

The Arab Drug Company specializes in the manufacture and sale of pharmaceutical products, catering to both human and animal health needs.

Product Portfolio

  • Anti-infectives
  • Central nervous system drugs
  • Dermatological drugs
  • Cardiovascular drugs
  • Animal health products (powders & solutions)

Global Reach

The company exports its products to 40+ countries, including key markets such as:

  • China, Korea, Turkey, Kazakhstan
  • Iraq, Syria, Jordan, Lebanon
  • Libya, Sudan, Somalia, Yemen, Morocco

Company Background

Founded in 1963, Arab Drug Company is headquartered in Cairo, Egypt.

Frequently Asked Questions

  • What is The Arab Drug Company's (EGX-ADCI) current market cap?
    As of 09/26/2025, The Arab Drug Company (including the parent company, if applicable) has an estimated market capitalization of $42.83 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • The Arab Drug Company global market capitalization ranking is approximately 31761 as of 09/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.